Children with physical disabilities are twice as likely to be bullied, impacting their educational, physical and emotional development.* In support of National Bullying Prevention Month this October, Shriners Hospitals for Children® and award-winning actor, model and philanthropist, RJ Mitte, are once again partnering to encourage the public to help #CutTheBull.
Teens and adults alike are encouraged to visit CutTheBull.org and see how they can help create a more positive, accepting environment for kids living with disabilities. There, Shriners Hospitals will announce “RJ's Heroes”, honoring individuals who have helped reduce bullying in their communities. Supporters can also share their anti-bullying stories and purchase #CutTheBull t-shirts, with proceeds going to Shriners Hospitals for Children to provide life-changing care to kids.
Born with cerebral palsy, Mitte was bullied as a child and knows firsthand the effects it can have. The doctors and staff at Shriners Hospitals for Children helped Mitte overcome many of the physical effects of cerebral palsy, which made him stronger and able to succeed despite the bullying. Now a successful actor and model, Mitte wants to help other kids with disabilities who may be experiencing the same thing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7559151-shriners-hospital-cut-the-bull/
With September marking National Prostate Cancer Awareness Month and the kick-off of the 2015 NFL season, the Urology Care Foundation and the NFL have renewed their commitment to driving prostate health awareness, as well as teamed up to highlight a Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to take charge of their health through the Know Your Stats® campaign.
The Know Your Stats® campaign is a rallying force to connect, educate and inspire men across the country to know their prostate cancer risk and talk to their doctor about whether prostate cancer testing is right for them.
“It is important for men to know their risk and talk to their doctors so they can determine if prostate cancer testing is right for them,” said Richard A. Memo, MD, Chair of the Urology Care Foundation. “Having the tools and facts empowers individuals and their doctors to make informed decisions.”
Prostate cancer is the second most common cancer in America, affecting one in seven men. Odds increase to one in five if they are African American and one in three if they have a family history; however, the educational tools are making an impact. More men are talking with their doctors and getting tested, and fewer men are dying from the disease.
To view the multimedia release go to:
http://www.multivu.com/players/English/7365551-prostate-cancer-know-your-stats-psa/
Personalised Medicine is the future of cancer treatment, but it presents major challenges for doctors and health services, the President of the European Society of Medical Oncology has said. Professor Rolf Stahel was speaking ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430351-professor-rolf-stahel-astellas-debate/
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, today released Marijuana on Main Street, a special report that provides an in-depth look at the debate over medical marijuana. As numerous states consider bills to legalize medical marijuana, WebMD surveyed nearly 3,000 consumers and Medscape surveyed more than 1,500 doctors about their attitudes regarding legalization, marijuana as a potential treatment option, and the perceived risks and benefits of its use to help shed light on this evolving issue.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7040258-webmd-medscape-medical-marijuana-report
Moms have been after their kids for years. Doctors, nutritionists, the government and gurus hound us but still, most Americans don’t eat enough vegetables. A recent Centers for Disease Control study shows no U.S. state is meeting the objectives for vegetable consumption. Now, Green Giant™ is introducing a simple solution: NEW Green Giant™ Veggie Blend-Ins™ 100% Carrot Purée, 100% Spinach Purée and 100% Butternut Squash Purée.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65725-general-mills-green-giant-veggie-blend-ins-jessica-seinfeld-vegout-purees
With the introduction of Abbott's iDesign Dx system, U.S. ophthalmologists now have a diagnostic tool that can capture five optical measurements in one three-second scan to determine the patient's visual abnormalities. This highly advanced diagnostic tool measures the internal optics and surface of the eye more precisely than conventional methods, allowing doctors to fully evaluate imperfections that result in poor vision. Obtaining these measurements in one three-second scan enables ophthalmologists to screen patients more efficiently to determine if they are eligible for LASIK or other refractive surgery and to assist in diagnosis of other conditions.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64467-abbott-idesign-dx-system-available-for-opthalmologists-and-patients
Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2™) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions in the consultation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64152-novo-nordisk-diabetes-report-doctor-treatment
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, today announced the launch of its Health Care Reform Center (webmd.com/myhealthcare) for consumers and the ACA Resource Center for physicians (medscape.com/resource/aca), examples of our commitment to educate consumers and physicians and to provide actionable guidance about the impact of the Affordable Care Act (ACA). The Health Care Reform Center will include a series of live chats with experts, offering consumers personalized information to prepare for future health insurance decisions and navigate the health insurance marketplace at any stage of their journey—from young Americans who were previously uninsured to older Americans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60046-webmd-health-care-reform-center-consumer-physician-educational-website
The Gout & Uric Acid Education Society (GUAES) has added six new educational videos for patients and medical professionals to its library of popular educational videos on gout, highlighting the society’s most important takeaways from the recently released American College of Rheumatology (ACR) Guidelines on Gout Diagnosis and Treatment. Available under the patient and medical professional portals on www.GoutEducation.org, respectively, the latest videos emphasize the need for continuous communication between gout patients and their doctors about their unique treatment plan, to help prevent gout flares and long-term complications from this poorly understood form of inflammatory arthritis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60699-gout-uric-acid-education-society-guaes-new-videos-on-acr-guidelines
Starting today, your smart phone can make you smarter about your health. Cigna is launching a new mobile app to help customers take better control of their health and health spending.
Throughout 2013 Cigna will release upgraded app capabilities, including accurate pricing and quality information on doctors and hospitals for more than 200 medical procedures according to the real-time status of the customer’s health plan and available health account funds.
To view Multimedia News Release, go to http://www.multivu.com/players/English/59191-cigna-mobile-app/
By reprogramming a 7–year–old girl’s own immune cells to attack an aggressive form of childhood leukemia, a pediatric oncologist has achieved a complete response in his patient, who faced grim prospects when she relapsed after conventional treatment. The innovative experimental therapy used bioengineered T cells, custom–designed to multiply rapidly in the patient, and then destroy leukemia cells. After the treatment, the child’s doctors found that she had no evidence of cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/50777-chop-engineered-immune-t-cell-therapy-anticancer-effect-in-children
